Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release

被引:116
作者
Eschenburg, S
Priestman, M
Schönbrunn, E
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66049 USA
[2] Max Planck Inst Med Res, Dept Biophys, D-69120 Heidelberg, Germany
关键词
D O I
10.1074/jbc.M411325200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MurA (UDP-N-acetylglucosamine enolpyruvyl transferase, EC 2.5.1.7) is an essential enzyme in the biosynthesis of the peptidoglycan layer of the bacterial cell. It provides an attractive template for the design of novel antibiotic drugs and is the target of the naturally occurring antibiotic fosfomycin, which covalently attaches to Cys(115) in the active site of the enzyme. Mutations of Cys(115) to Asp exist in pathogens such as Mycobacteria or Chlamydia rendering these organisms resistant to fosfomycin. Thus, there is a need for the elucidation of the role of this cysteine in the MurA reaction. We determined the x-ray structure of the C115S mutant of Enterobacter cloacae MurA, which was crystallized in the presence of the substrates of MurA. The structure depicts the product state of the enzyme with enolpyruvyl-UDP-N-acetylglucosamine and inorganic phosphate trapped in the active site. Kinetic analysis revealed that the Cys-to-Ser mutation results in an enzyme that appears to perform a single turnover of the reaction. Opposing the common view of Cys(115) as a key residue in the chemical reaction of enolpyruvyl transfer, we now conclude that the wild-type cysteine is essential for product release only. On the basis of a detailed comparison of the product state with the intermediate state and an unliganded state of MurA, we propose that dissociation of the products is an ordered event with inorganic phosphate leaving first. Phosphate departure appears to trigger a suite of conformational changes, which finally leads to opening of the two-domain structure of MurA and the release of the second product enolpyruvyl-UDP-N-acetylglucosamine.
引用
收藏
页码:3757 / 3763
页数:7
相关论文
共 39 条
[1]   INHIBITION OF EPSP SYNTHASE BY ANALOGS OF THE TETRAHEDRAL INTERMEDIATE AND OF EPSP [J].
ALBERG, DG ;
LAUHON, CT ;
NYFELER, R ;
FASSLER, A ;
BARTLETT, PA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (09) :3535-3546
[2]   5-enolpyruvylshikimate 3-phosphate synthase: Chemical synthesis of the tetrahedral intermediate and assignment of the stereochemical course of the enzymatic reaction [J].
An, M ;
Maitra, U ;
Neidlein, U ;
Bartlett, PA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (42) :12759-12767
[3]   THE SHIKIMATE PATHWAY - A METABOLIC TREE WITH MANY BRANCHES [J].
BENTLEY, R .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 25 (05) :307-384
[4]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[5]   Nonenzymatic breakdown of the tetrahedral (α-carboxyketal phosphate) intermediates of MurA and AroA, two carboxyvinyl transferases.: Protonation of different functional groups controls the rate and fate of breakdown [J].
Byczynski, B ;
Mizyed, S ;
Berti, PJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (41) :12541-12550
[6]   Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis [J].
De Smet, KAL ;
Kempsell, KE ;
Gallagher, A ;
Duncan, K ;
Young, DB .
MICROBIOLOGY-UK, 1999, 145 :3177-3184
[7]   Structure and function of the Mur enzymes: development of novel inhibitors [J].
El Zoeiby, A ;
Sanschagrin, F ;
Levesque, RC .
MOLECULAR MICROBIOLOGY, 2003, 47 (01) :1-12
[8]   How the mutation glycine96 to alanine confers glyphosate insensitivity to 5-enolpyruvyl shikimate-3-phosphate synthase from Escherichia coli [J].
Eschenburg, S ;
Healy, ML ;
Priestman, MA ;
Lushington, GH ;
Schönbrunn, E .
PLANTA, 2002, 216 (01) :129-135
[9]   A new view of the mechanisms of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate-3-phosphate synthase (AroA) derived from X-ray structures of their tetrahedral reaction intermediate states [J].
Eschenburg, S ;
Kabsch, W ;
Healy, ML ;
Schönbrunn, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :49215-49222
[10]  
Eschenburg S, 2000, PROTEINS, V40, P290, DOI 10.1002/(SICI)1097-0134(20000801)40:2<290::AID-PROT90>3.0.CO